• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

38
22
19
15
15

COUNTRY

21
17
15
15
15

CATEGORIES

  • 35
  • 34
  • 22
  • 10
  • 6
  • 6
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

4
19
38
88

PUBLISHED

0
8
57
88

PRODUCT TYPE

72
16

Search "China Biologic Products, Inc.-Therapeutic Competitors" returned 88 results.

PRODUCT TITLE
Biologic Drug R&D in China - Current State and Future Development Biologic Drug R&D in China - Current State and Future Development - Product Thumbnail Image

Biologic Drug R&D in China - Current State and Future Development

The fast growth of the Chinese bio-pharmaceutical market has been prompting the rapid development of the entire Chinese bio-pharmaceutical industry, including R&D on biological medicines In the recent...

May 2013
FROM
Comparison of Biopharmaceutical Industry between China and India 2013 Comparison of Biopharmaceutical Industry between China and India 2013 - Product Thumbnail Image

Comparison of Biopharmaceutical Industry between China and India 2013

It has been widely recognized that biopharmaceuticals have become not only a new class of therapeutics for those diseases previously treated with small molecule drugs but also a type of innovative treatment...

March 2013
FROM

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

“Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies” provides the key data and analyzes...

September 2010
FROM
The New Trends of Global Drug Discovery Outsourcing 2013 The New Trends of Global Drug Discovery Outsourcing 2013 - Product Thumbnail Image

The New Trends of Global Drug Discovery Outsourcing 2013

After having focused on the late stage drug development for several years, the global major pharmaceutical and biopharmaceutical companies have now all realized that they need to refocus on early stage...

September 2013
FROM
Competitor Analysis: Erythropoietin (EPO) Competitor Analysis: Erythropoietin (EPO) - Product Thumbnail Image

Competitor Analysis: Erythropoietin (EPO)

The Competitive Intelligence Report Erythropoietin (EPO) & Erythropoiesis Stimulating Agents (ESA) as of January 2011 in its 5th edition provides information on existing first and second generation...

January 2011
FROM

Bioseparation Systems for Global Biopharmaceutical Markets

Bioseparations systems can be categorized into three types: chromatography, membranes/filters and centrifuges The demand for single use products is increasing and fueling growth of the global bioseparations...

August 2013
FROM
The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology - Product Thumbnail Image

The New Trends of Global Pharmaceutical Outsourcing: New Developments in Strategy, Market, Service and Technology

It has been widely recognized that the global pharmaceutical industry is currently experiencing dynamic change Primarily due to the low success rate of drug R&D, all world pharmaceutical companies are...

October 2011
FROM

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, “Upstream Processing in Biopharmaceuticals...

March 2011
FROM
Growth Factors (Blood and Tissue) - Global Strategic Business Report Growth Factors (Blood and Tissue) - Global Strategic Business Report - Product Thumbnail Image

Growth Factors (Blood and Tissue) - Global Strategic Business Report

This report analyzes the worldwide markets for Growth Factors (Blood and Tissue) in US$ Million by the following Types: Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons,...

June 2014
FROM

China National Biotec Group - Strategic SWOT Analysis Review

China National Biotec Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a...

March 2014
FROM
Regenerative Medicine - Global Strategic Business Report Regenerative Medicine - Global Strategic Business Report - Product Thumbnail Image

Regenerative Medicine - Global Strategic Business Report

This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World....

June 2014
FROM
Blood Banking And Blood Products - Global Strategic Business Report Blood Banking And Blood Products - Global Strategic Business Report - Product Thumbnail Image

Blood Banking And Blood Products - Global Strategic Business Report

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components,...

October 2012
FROM

Global Flow Cytometry Market

Flow cytometry is a laboratory analytical technique that can rapidly measure multiple parameters of individual cells or particles as they pass through a beam of light, typically a laser The global flow...

May 2014
FROM
Competitor Analysis: G-CSF and GM-CSF Competitor Analysis: G-CSF and GM-CSF - Product Thumbnail Image

Competitor Analysis: G-CSF and GM-CSF

he present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets...

April 2013
FROM

PharmaSphere: Global Dealmaking and Operations Strategies in the CRO Market

PharmaSphere: Global Dealmaking and Operations Strategies in the CRO Market Summary "PharmaSphere: Global Dealmaking and Operations Strategies in the CRO Market" report covers the dealmaking activity...

September 2013
FROM

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

September 2013
FROM
The New Trends of Global Biomanufacturing Outsourcing The New Trends of Global Biomanufacturing Outsourcing - Product Thumbnail Image

The New Trends of Global Biomanufacturing Outsourcing

The fast growth of the global bio-pharmaceutical market has prompted all global major pharmaceutical companies to increase their R&D investment in biologics The increasing availability of funding opportunities...

July 2014
FROM

Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost - Effective Purification Technologies

“Down Stream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost-effective Purification Technologies”, provides the key data and analyzes the major challenges...

November 2010
FROM

Eczema - Pipeline Review, H1 2014

Eczema - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Eczema - Pipeline Review, H1 2014’, provides an overview of the Eczema’s therapeutic pipeline. This report provides comprehensive...

April 2014
FROM

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014 Summary This, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014’, provides an overview of the Fibrinogen...

September 2014
FROM
Loading Indicator

Our Clients

Hexcel Corporation Harrods Ltd. Bayer AG Google, Inc. Boeing Company Harley Davidson Motor Company SwissCom AG